Does PIMECROLIMUS Cause Therapeutic product effect incomplete? 65 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Therapeutic product effect incomplete have been filed in association with PIMECROLIMUS (Pimecrolimus). This represents 4.9% of all adverse event reports for PIMECROLIMUS.
65
Reports of Therapeutic product effect incomplete with PIMECROLIMUS
4.9%
of all PIMECROLIMUS reports
0
Deaths
3
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From PIMECROLIMUS?
Of the 65 reports, 3 (4.6%) required hospitalization.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIMECROLIMUS. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does PIMECROLIMUS Cause?
Drug ineffective (349)
Treatment failure (139)
Psoriasis (114)
Off label use (113)
Pruritus (94)
Erythema (89)
Product use in unapproved indication (86)
Rash (82)
Application site pain (72)
Condition aggravated (59)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which PIMECROLIMUS Alternatives Have Lower Therapeutic product effect incomplete Risk?
PIMECROLIMUS vs PIMOZIDE
PIMECROLIMUS vs PINAVERIUM
PIMECROLIMUS vs PINDOLOL
PIMECROLIMUS vs PIOGLITAZONE
PIMECROLIMUS vs PIPAMPERONE